Penicillamine — an Anglo-American Adventure in the Treatment of Rheumatoid Arthritis
- 22 March 1973
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 288 (12) , 630-631
- https://doi.org/10.1056/nejm197303222881211
Abstract
The discovery of penicillin by Sir Alexander Fleming, and its subsequent purification by Florey and Chain at Oxford, was translated into clinical usefulness by a team of chemists and microbiologists at the Northern Regional Research Laboratory in Peoria, Illinois. This transatlantic collaboration has continued through the years with respect to one of the degradation products of penicillin — penicillamine, which was first discovered by the Oxford group in 1943.1 Ten years later, John Walshe, while working on the Harvard Division of the Boston City Hospital, first identified penicillamine in the urine of patients with liver disease who were receiving penicillin. . . .Keywords
This publication has 8 references indexed in Scilit:
- CONTROLLED TRIAL OF D(-)PENICILLAMINE IN SEVERE RHEUMATOID ARTHRITISThe Lancet, 1973
- The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamineArthritis & Rheumatism, 1970
- Effect of Penicillamine on CystinuriaBMJ, 1963
- Comparison of the Effect of Plasmapheresis and Penicillamine on the Level of Circulating Rheumatoid FactorAnnals of the Rheumatic Diseases, 1963
- The long term management of hepatolenticular degeneration (Wilson's disease)The American Journal of Medicine, 1960
- WILSON'S DISEASE: NEW ORAL THERAPYThe Lancet, 1956
- A New Mixed Disulphide: Penicillamine–CysteineNature, 1954
- Penicillamine, a Characteristic Degradation Product of PenicillinNature, 1943